Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Gold Nanoparticles as Novel Biomarkers for Cancer Stem Cells in Salivary Gland Tumors: A Diagnostic and Prognostic Accuracy Study

NCT04907422 is registered in ClinicalTrials.gov with Amina Fouad Farag as lead sponsor.

NCT NCT04907422
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04907422 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Gold Nanoparticles as Novel Biomarkers for Cancer Stem Cells in Salivary Gland Tumors: A Diagnostic and Prognostic Accuracy Study
Lead sponsor
Amina Fouad Farag
Phase
Observational
Overall status
Completed
Start date
August 6, 2018
Completion date
February 3, 2021
Enrollment
60 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

carcinoma ex pleomorphic adenoma of salivary glands, pleomorphic adenoma of salivary glands